Unnikrishnan

The protesters are calling for a minimum monthly salary of Rs 40,000, improved working conditions, and an end to exploitative contractual jobs. 🔗tinyurl.com/4ne759b8 ✍️@unitune6,📸@PulickalVincent

In a striking shift in investment habits, Kerala’s presence in the national Stock exchange (NSE) — the country’s largest bourse — has soared to nearly 32 lakh unique investors. this marks a 3.4-fold increase since the Covid era. 🔗shorturl.at/djyB0 ✍️@unitune6

The last time double-digit growth happened was in 2017, when it touched 10.3%, before floods and the Covid pandemic dampened demand, @unitune6 writes. 🔗shorturl.at/3SbH1 @MSKiranPrakash @PaulCithara #VehicleRegistration #Economy #Kerala

Under this new initiative, drivers and conductors will undergo behavioural training at the Police Training College in Thiruvananthapuram. 🔗shorturl.at/VYHaH ✍️@unitune6

@theliverdoc newindianexpress.com/states/kerala/… The study report published in @xpresskerala @NewIndianXpress

STAY WITH ME. A few years ago, a patient was referred to me because he was diagnosed with complicated cirrhosis. He had an infection which led to a condition called hepatic encephalopathy (brain failure due to high ammonia levels). The treatment largely involved ammonia reducing therapies. One drug was central to this - Rifaximin - a non-absorbable antibiotic that reduced ammonia in the body. I prescribed him Rifaximin for 6 weeks and advised him follow-up. He came back to me, not after six weeks, but in 4 weeks, this time, in liver coma (worst stage of brain failure - due to very high ammonia). He spent two days in the ICU and six days in total in the hospital. His hospital bill was close to INR 80,000. He had no insurance and his wife borrowed the money from neighbors and friends to clear hospital dues. Upon questioning, I found that he was not taking the Rifaximin drug I had prescribed. He was only on the other two drugs (one, a syrup called lactulose for improving ammonia clearance in gut). I was furious, because the patient spent a whole week unecessarily in the ICU and wasted so much money that he never had - just because he was "not compliant" to my orders. I decided it was time for me to school him a bit. But I was wrong. He was compliant. He had purchased Rifaximin and was on it. For 15 days. Thereafter, he could not afford it. He was an autorickshaw driver who shuttled school children every morning and evening. He could hardly make ends meet. He had two children of his own. The Rifaximin brand I prescribed him was 42 rupees per tablet. He had to consume two a day - which would mean 2520 rupees a month. He just did not have that money - so he skipped it - to not compromise on other important matters - childrens education and food. He was confused and scared about opting for a cheaper version of Rifaximin because one, he was unsure about the quality of Rifaximin that was not prescribed by me and two, he was "scared" that I would scold him for buying a cheaper Rifaximin and if that got him into trouble. I was confused and scared about prescribing a cheaper version of Rifaximin because one, I was unsure about the quality of Rifaximin that was not "a good promoted brand" and two, I was "scared" that his family would scold me for prescribing a cheaper Rifaximin and if that got him into trouble. It is heartbreaking that many doctors still simply don’t trust generic medicines. Too often, they worry that these cheaper options are lower quality or might cause more problems than the big, famous brands. This fear leads them to prescribe expensive drugs instead, and the real tragedy is that it pushes vital healthcare out of reach for the ordinary people who need it most - like my patient. This narrative, that generic drugs 'are never good' and that only big pharmaceutical marketed drugs are what works has been deeply ingrained into doctors and patients alike - I do not know by whom and since when. Looking back, these strong emotions were based on either opinions, testimonials or second- and third-hand information. Not evidence. Like I said. Stay with me. This is life changing and will disrupt the drug market in India. Here are the results of The Citizens Generic vs. Brand Drugs Quality Project. 1/11

No nation can emerge without fearless literature and journalism, says Honourable Vice President CP Radhakrishnan at the third Ramnath Goenka Sahithya Samman. #RamnathGoenkaSahithyaSamman #IndianLiterature #Books #Authors #TheNewIndianExpress @santwana99 @etteth @CPR_VP @PrabhuChawla

Honourable Vice President Shri CP Radhakrishnan joins us as the chief guest at the third Ramnath Goenka Sahithya Samman in Chennai. Watch it LIVE here 👇 youtube.com/live/GaCuFF7T8… @santwana99 @etteth @CPR_VP

@CPR_VP @PrabhuChawla @santwana99 @DinamaniDaily @KVaidiyanathan Honourable Vice President Shri CP Radhakrishnan (@CPR_VP) being felicitated at the Ramnath Goenka Sahithya Samman ceremony in Chennai. #RamnathGoenkaSahithyaSamman #IndianLiterature #Books #Authors #TheNewIndianExpress @santwana99 @etteth @PrabhuChawla

The wait is over! Here’s the fiction shortlist for the 3rd Ramnath Goenka Sahithya Samman. Heart Lamp by Banu Mushtaq, Tales from the Dawn-Lit Mountains by Subi Taba and The Girl with the Seven Lives by Vikas Swarup are the three contenders here. Winners of the 3rd Ramnath Goenka Sahithya Samman will be announced in Chennai on January 2, 2026. Stay tuned for more stories, more voices, more literature coming your way! #RamnathGoenkaSahithyaSamman #IndianLiterature #Books #Authors #TheNewIndianExpress @SubiTaba @VikasSwarup @BanuMushtaq @santwana99 @etteth

#Jury’s Out Author, Diplomat and jury chair of Ramnath Goenka Sahithya Samman Pavan Varma talks about 2025 shortlist. Winners of the 3rd Ramnath Goenka Sahithya Samman to be announced in Chennai on January 2, 2026. Stay tuned for more stories, more voices, more literature coming your way! #RamnathGoenkaSahithyaSamman #IndianLiterature #Books #Authors #TheNewIndianExpress @PavanK_Varma @santwana99 @etteth

#Flashback Acclaimed writer Aishwarya Jha, winner of the 2024 RNG Sahithya Samman (Fiction), reflects on her literary journey. Winners of the 3rd Ramnath Goenka Sahithya Samman to be announced in Chennai on January 2, 2026. Stay tuned for more stories, more voices, more literature coming your way! #RamnathGoenkaSahithyaSamman #IndianLiterature #Books #Authors #TheNewIndianExpress @theladyjha @santwana99 @etteth

Malappuram, which once reported the highest number of home births in Kerala, has witnessed a remarkable turnaround this year with an 80% drop in such cases. 🔗shorturl.at/9f0G2 ✍️@unitune6

#Starspeak David Davidar (Author & Co-founder, Aleph) shares his insights on the Ramnath Goenka Sahithya Samman where literature meets legacy. Winners of the 3rd Ramnath Goenka Sahithya Samman to be announced in Chennai on January 2, 2026. Stay tuned for more stories, more voices, more literature coming your way! #RamnathGoenkaSahithyaSamman #IndianLiterature #Books #Authors #TheNewIndianExpress @santwana99 @etteth

Among southern states, Tamil Nadu and Karnataka reported a higher annual caseload, but were behind Kerala in per capita cancer incidence. 🔗shorturl.at/NV9M5 ✍️@unitune6

Generic drugs vs. Branded drugs project An update. Within 24 hours, we were able to raise ₹1200,000/- with you kind support. This is massive - a sign of great interest from the public. Help us keep it alive. The whole project cost is ₹2793000/- including detailed analysis work, purchase, transportation, logistics, future paper publication and open access fees. We do not have any sponsors other than you. Please help us reach the goal so that this project sees the light at the end of the tunnel. There is no other major public health project that is so important in India right now. And you can help us go the distance. To contribute, please go here: pages.razorpay.com/GenericvsBrand… - and share this with your family and friends. If you have entrepreneurs or business owners who are interested in not-for-profit healthcare projects like these and would like to contribute larger sums to this public health project, please get in touch with them too with the link and project details. We want to kick-off the analyses early next week.

@amey_zagade @WeekendInvestng bro, In a country where over 20 children died recently after consuming a spurious cough syrup due to lax regulation, we are living with far bigger failures. Do we really need to worry about people choosing brown or purple eggs?

@unitune6 @WeekendInvestng Whatever it is, we should avoid drawing a line in such cases. Who know if today they use food safe colours and later switch to toxic ones. We all know that in reality lot of things are contaminated and regulatory body is toothless in acting against the offenders.

until you start hanging people this will go on

What this Left government has done is just amazing. And the role played by KIIFB is pivotal. We got the reclusive K M Abraham, its CEO, to open up. #Kerala @pinarayivijayan @drthomasisaac youtu.be/xsRkPZ_A-XI?si…

A landmark study finds high CKD prevalence among India's indigenous tribes. Urgent call for equity driven, culturally adapted CKD prevention within primary care. @NITIAayog @ICMRDELHI @ncdalliance @MoHFW_INDIA @unitune6 @VeenaGeorge03 @TribalAffairsIn kireports.org/article/S2468-…